[The therapeutic action of recombinant human interleukin-2 (IL-2) in experimental acute radiation sickness].
In experiments with CBA mice and non-purebred dogs the pronounced medicinal effect was found. Injections of IL-2 had been going 3 times per day for 5 days beginning with 6 h after exposure. The optimum doses of IL-2 were 20.10(3) U/kg day for mice and 3.10(3) U/kg day for dogs. By this scheme of IL-2 application the survival of mice exposed to LD75 and LD90 and dogs exposed to LD86 raised up to 100%, 70% and 70%, respectively.